早期肝癌的经皮局部治疗：东西方视角

Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives.

作者信息

Iezzi Roberto, Posa Alessandro, Contegiacomo Andrea, Lee In Joon, Bale Reto, Tanzilli Alessandro, Tenore Lorenzo, Giuliante Felice, Gasbarrini Antonio, Goldberg Shraga Nahum, Jakobs Tobias, Pompili Maurizio, Bargellini Irene, Sala Evis, Kim Hyo-Cheol

机构信息

Department of Diagnostic Imaging, Oncologic Radiotherapy and Hematology, A. Gemelli University Hospital Foundation IRCCS, 00168 Rome, Italy.

School of Medicine, Catholic University of the Sacred Heart, 00168 Rome, Italy.

出版信息

Cancers (Basel). 2023 Aug 6;15(15):3988. doi: 10.3390/cancers15153988.

DOI:10.3390/cancers15153988

PMID:37568804

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10416919/

Abstract

Hepatocellular carcinoma represents an important cause of death worldwide. Early-stage hepatocellular carcinoma patients not suitable for surgery can be treated with a variety of minimally invasive locoregional interventional oncology techniques. Various guidelines in different countries address the treatment of hepatocellular carcinoma, but the actual treatment is usually discussed by a multidisciplinary tumor board in a personalized manner, leading to potential treatment differences based on Western and Eastern perspectives. The aim of this paper is to integrate literature evidence with the eminent experiences collected during a focused session at the Mediterranean Interventional Oncology (MIO) Live Congress 2023.

摘要

肝细胞癌是全球范围内一个重要的死亡原因。不适合手术的早期肝细胞癌患者可采用多种微创局部区域肿瘤介入技术进行治疗。不同国家的各种指南都涉及肝细胞癌的治疗，但实际治疗通常由多学科肿瘤委员会以个性化方式进行讨论，这导致基于西方和东方观点可能存在治疗差异。本文的目的是将文献证据与在2023年地中海介入肿瘤学（MIO）现场大会的一次专题会议期间收集的卓越经验相结合。